InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Thursday, 03/09/2017 2:28:22 PM

Thursday, March 09, 2017 2:28:22 PM

Post# of 18784
Since Doxorubicin is also used in the treatment for prostate and ovarian cancer, the P3 results for endometrial cancer will determine the entire future of AEZS. If Zoptrex shows significant efficacy and safety vs Doxorubicin now,it will garantee success for prostate and ovarian cancer as well. In other words success should be valued in a MC above 1billion dollar. 1 billion dollar/20 million shares (included 7million shares extra as dilution)= $50/share
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News